Fasnall
Fasnall is a selective fatty acid synthase (FASN) inhibitor that targets co-factor binding sites. It exhibits significant anti-tumor efficacy in HER2+ breast cancer models, particularly in combination with carboplatin, supporting research in oncology and metabolic pathways through in vitro and in vivo studies.
Product Specifications
CAS Number
929978-58-5
Product Name Alternative
Fasnall, Fatty Acid Synthase, Fatty Acid Synthase (FASN), FattyAcidSynthase
Field of Research
Cell Biology, Metabolism Research
Purity
90.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:1 mg/mL (2.95 mM) ; Ethanol:20 mg/mL (59.09 mM) ; DMSO:10 mg/mL (29.54 mM)
Smiles
N (C1=C2C (SC (C) =C2C) =NC=N1) C3CN (CC4=CC=CC=C4) CC3
Molecular Formula
C19H22N4S
Molecular Weight
338.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A34006-APC 100 µg/Vial
Anti-SARS-CoV-2 NSP14/Exonuclease Antibody, APC Conjugate
Sign In for Pricing
View Details 